NeilWarrenSchlugerMD

PubMed

• Epidemiology and Outcomes of Critical Illness and Novel Predictors of Mortality in an Ethiopian Medical Intensive Care Unit.
  Aschalew Worku, Deborah Haisch, Madhavi Parekh, Amir Sultan, Abebe Shumet
  Journal of Intensive Care Medicine. 2024-08-01
• Clinical characteristics, imaging, and lung function among patients with persistent dyspnea of COVID-19: a retrospective observational cohort study.
  Ravi Manglani, Moshe Fenster, Theresa Henson, Ananth Jain, Neil Schluger
  Monaldi Archives for Chest Disease = Archivio Monaldi per Le Malattie Del Torace. 2024-05-06
• 1 citations
  Long-term outcome of co-infection of COVID-19 and tuberculosis: the "cursed duet".
  Roland Diel, Neil W Schluger
  The European Respiratory Journal. 2023-11-01

Journal Articles

• Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19  
  Neil Schluger, MD, The New England Journal of Medicine
• Precision Surveillance for Viral Respiratory Pathogens: Virome Capture Sequencing for the Detection and Genomic Characterization of Severe Acute Respiratory Infection ...  
  Neil W Schluger, Clinical Infectious Diseases
• Tuberculosis report among injection drug users and their partners in Kazakhstan  
  Hermosilla S, El-Bassel N, Aifah A, Terlikbayeva A, Zhumadilov Z, Berikhanova K, Darisheva M, Gilbert L, Schluger N, Galea S, Public Health, 1/17/2015
• Daily rifapentine for treatment of pulmonary tuberculosis: a randomized, dose ranging trial  
  Dorman SE, Savic RM, Goldberg S, Stout JE, Schluger NW, Muzanyi G, Johnson JL Nahid P, Hecker EJ, Heilig CM, Bozeman L, Feng P-J, Moro RN, Mac Kenzie W, Dooley KE, Nue..., Amer J Respir Crit Care Med, 1/1/2015
• Notes from the field: training pulmonary specialists in a low-income country  
  Schluger N, Sherman C, Annals Amer Thor Soc, 1/1/2015
• Epidemiologic correlates of pyrazinamide resistant Mycobacterium tuberculosis in New York City  
  Verdugo D, Fallows D, Ahuja S, Schluger N, Kreiswirth B, Mathema B, Antimicrob Agents Chemother, 1/1/2015
• Interferon-gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States  
  Dorman, SE, Belknap, R, Graviss, EA, Reves, R, Schluger N, Weinfurter P, Wang Y, Cronin W, Hirsch-Moverman Y, Teeter LA, Parker M, Garrett DO, and Daley CL, for the Tu..., Am J Respir Crit Care Med, 1/1/2014
• Lung Disease in a Global Context: A Call for Public Health Action  
  Schluger N and Kopakka R, Annals of the American Thoracic Society, 1/1/2014
• The growing challenge of nontuberculous mycobacteria  
  Schluger NW, Chest, 1/1/2014
• Household air quality in high-income countries: forgotten but not gone  
  Schluger NW, Lancet Respiratory Medicine, 1/1/2014
• The electronic cigarette: a knight in shining armour or a Trojan horse?  
  Schluger NW, Psychiatr Bull, 1/1/2014
• Variability in interferon gamma release assay results and screening for tuberculosis A way forward?  
  Schluger NW, Burzynski J, Ann Am Thorac Soc, 1/1/2014
• Update in Mycobacterial Disease 2013  
  Reves R. and Schluger N, American Journal of Respiratory and Critical Care Medicine, 1/1/2014
• CT pulmonary angiography: increasingly diagnosing less severe pulmonary emboli  
  Schissler AJ, Rozenshtein A, Kulon ME, Pearson GD, Green RA, Stetson PD, Brenner DJ, D'Souza B, Tsai WY, Schluger NW, Einstein AJ, PLoS One, 1/12/2013
• Tuberculosis, drug use and HIV infection in Central Asia: An urgent need for attention  
  Schluger NW, El-Bassel N, Hermosilla S, Terlikbayeva A, Darisheva M, Aifah A, Galea S, Drug Alcohol Depend, 1/1/2013
• Fluoroquinolones in the Treatment of Tuberculosis: Which Is Best?  
  Schluger NW, Am J Respir Crit Care Med, 1/1/2013
• Tiotropium Respimat inhaler and the risk of death in COPD  
  Data Safety Monitoring Board, TIOSPIR Trial, N Engl J Med, 1/1/2013
• Interferon-gamma release assay versus tuberculin skin test across RA, PsA, and AS patients prior to treatment with golimumab, a human anti-TNF antibody  
  Hsia EC, Schluger N, Cush J, Chaisson RE, Matteson EL, Xu S, Beutler A, Doyle MK, Hsu B, Rahman MU, Arthritis and Rheumatism, 1/1/2012
• Sildenafil for Chronic Obstructive Pulmonary Disease: A Randomized Crossover Trial  
  Lederer DJ, Bartels MN, Schluger NW, Brogan F, Jellen P, Thomashow BM, Kawut SM, COPD: Journal Of Chronic Obstructive Pulmonary Disease, 1/1/2012
• Substitution of Rifapentine for Rifampin during Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium  
  Dorman SE, Goldberg S, Stout JE, Muzanyi G, Johnson JL, Weiner M, Bozeman L, Heilig CM, Feng P-J, Moro R, Narita M, Nahid P, Ray S, Bates E, Haile B, Nuermberger EL, V..., Journal of Infectious Diseases, 1/1/2012
• Diagnosis and Management of Tuberculosis in Transplant Donors  
  Morris MI, Daly JS, Blumberg E, Kumar D, Sester M, Schluger N, Kim S-H, Schwartz BS, Ison MG, Humar A, Singh N, Michaels M, Orlowski JP, Delmonico F, Pruett T, John GT..., American Journal of Transplantation, 1/1/2012
• Tuberculosis in Kazakhstan: analysis of risk determinants in the national surveillance data  
  Terlikbayeva AM, Hermosilla S, Galea S, Schluger N, Abildayev T, Yegeubayeva S, Muminov T, Akiyanova F, Bartkowiak L, Zhumadilov Z, Sharman A and El-Bassel N, BMC Infectious Diseases, 1/1/2012
• Treatment of Pulmonary Mycobacterium avium Complex Infections: Do Drug Levels Matter?  
  Schluger NW, Am. J. Respir. Crit. Care Med., 1/1/2012
• Three months of rifapentine and isoniazid for latent tuberculosis infection  
  Sterling T., Villarino M., Borisov A, Shang A, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton C, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde M, Bozeman L..., N Engl J Med, 1/1/2011
• The Tuberculosis Trials Consortium: A Model for Clinical Trials Collaborations  
  Tuberculosis Trials Consortium, Public Health Reports, 1/1/2011
• Join now to see all

Books/Book Chapters

• The Tobacco Atlas 
  Eriksen M, Mackay J, Schluger N, Gomeshtapeh F, Drope JAmerican Cancer Society/World Lung Foundation, AtlantaEdition 5th,2015
• Aging and the Lung: A Clinical Guide 
  Chapter: Nontuberculous mycobacterial infections in older patients. 
  Parekh M, Kamelhar D, and Schluger NEditors: Pisani M.Springer, NY2012
• The Acute Respiratory Infections Atlas 
  Schluger NWWorld Lung Foundation, NY2010
• AIDS and Tuberculosis: A Deadly Liaison 
  Chapter: HIV-associated Tuberculosis: Clinical Challenges 
  Schluger NWEditors: Kaufmann SHE and Walker BD.Wiley-Blackwell, Weinheim2009
• Tuberculosis: A Conprehensive Clinical Reference 
  Chapter: Nucleic Acid Amplification for Detection of Mycobacterium tuberculosis 
  Brodie D and Schluger NWEditors: Schaff HS and Zumla A.Saunders/Elsevier, London2009
• Emerging Infections 8 
  Chapter: Multidrug resistant and extensively drug resistant tuberculosis. 
  Schluger NWEditors: Scheld W, Hughes J and Hammer S.ASM Press, Washington2008
• Handbook of Tuberculosis: Clinics, Diagnostics, Therapy and Epidemiology 
  Chapter: Chemotherapy of Tuberculosis. 
  Schluger NWEditors: Kaufmann SHE and van Helden P.Wiley-VCH, Weinheim2008
• Clinics in Chest Medicine 
  Chapter: Tuberculosis and non-tuberculous mycobacterial infections in older adults. 
  Page 773 - 781Schluger NW2007
• Emerging Infectious Diseases 
  Chapter: Multidrug-resistant Tuberculosis 
  Schluger NWEditors: Lashley FR and Durham JD.Springer Publishing Company, NY2007
• Encyclopedia of Respiratory Medicine 
  Chapter: Vaccinations for Bacterial Pneumonia 
  Schluger NWEditors: Laurent G and Shapiro S.Elsevier, London2006
• Encyclopedia of Respiratory Medicine 
  Chapter: Mycobacterial Pneumonias 
  Schluger NW and Burzynski JEditors: Laurent G and Shapiro S.Elsevier, London2006
• Tuberculosis. Clinics in Chest Medicine 
  Schluger NW2005
• Tuberculosis 
  Chapter: Tuberculosis and human immunodeficiency virus infection. 
  Burzynski J, Schluger NW, and Garay SMEditors: Rom WN and Garay SM.Lippincott Williams and Wilkins, PhiladelphiaEdition 2nd,2003
• Tuberculosis 
  Chapter: Novel approaches to the rapid diagnosis of tuberculosis. 
  Schluger NWEditors: Rom WN and Garay SM.Lippincott Williams and Wilkins, PhiladelphiaEdition 2nd,2003
• Emerging Infectious Diseases: Trends and Issues 
  Chapter: Multidrug resistant tuberculosis. 
  Schluger NWSpringer Publishing, NY2002
• Lung Volume Reduction Surgery 
  Chapter: Pathogenesis and pathophysiology of emphysema. 
  Schluger NW, D'Armiento JEditors: Agenziano M and Ginsburg M.Humana Press, NY2001
• Radiologic Diagnosis of Chest Disease 
  Chapter: Pulmonary disease in the immunocompromised host. 
  Schluger NW, Pearson GEditors: Sperber M.Springer-Verlag, London2001
• Occupational Medicine Secrets 
  Chapter: Tuberculosis 
  Schluger, NWEditors: Bowler RM and Cone JE.Hanley and Belfus, Philadelphia1999
• Molecular Biology of the Lung 
  Chapter: The role of the polymerase chain reaction in the diagnosis of respiratory tract infections. 
  Schluger, NWEditors: Stockley RA.Birkhauser Verlag, Basel1999
• Environmental and Occupational Medicine 
  Chapter: Occupational tuberculosis. 
  Sepkowitz K, Schluger NWEditors: Rom WN.Lippincott-Raven, Boston1998
• Respiratory Care Pearls 
  Mazzagatti F, Lebowitz L, Schluger, NWHanley and Belfus, Philadelphia1997
• Pulmonary and Respiratory Therapy Secrets 
  Chapter: Tuberculosis 
  Schluger NEditors: Heffner J and Parsons P.Hanley and Belfus, Philadelphia1997
• Tuberculosis 
  Chapter: Tuberculosis and the health care worker. 
  Sepkowitz K, Schluger NWEditors: Rom WN and Garay S.Little, Brown and Co., Boston1996
• Tuberculosis Pearls 
  Schluger NW, Harkin THanley and Belfus, Philadelphia1996
• Tuberculosis 
  Chapter: The polymerase chain reaction in the diagnosis of tuberculosis 
  Schluger NWEditors: Rom WN and Garay S.Little, Brown and Co., Boston1996
• Join now to see all

Lectures

• The Global Tobacco Epidemic. 
  Christiana Hospital, Wilmington, DE - 1/1/2016
• Community Engagement in Tuberculosis Clinical Trials. 
  Cape Town, South Africa - 1/1/2015
• Challenges of translating basic science into improved regimens for latent and active tuberculosis. 
  Girona, Spain - 1/1/2015
• Challenges of pulmonary infections with non-tuberculous mycobacteria. 
  Jerusalem, Israel - 1/1/2015
• The East African Training Initiative in Pulmonary Medicine. 
  Sitges, Spain - 1/1/2015
• The Global Tuberculosis Epidemic: Implications for TB Control At Home and Abroad. 
  New York Methodist Hospital, Brooklyn, NY - 1/1/2015
• Why Can't We Make Tuberculosis Go Away? 
  Vancouver, Canada - 1/1/2015
• Transmission and Pathogenesis of Tuberculosis. 
  Global Tuberculosis Institute, Rutgers, The State University of New Jersey - 1/1/2014
• Advances in the treatment of latent and active tuberculosis. 
  Brooklyn, NY - 1/1/2014
• New Approaches to Treatment of Latent and Active Tuberculoisis. 
  Hofstra University School of Medicine, North Shore/Long Island Jewish Medical Center - 1/1/2014
• Progress in Eliminating Tuberculosis. 
  Shaare Zedek Medical Center, Jerusalem - 1/1/2014
• Treatment of pulmonary disease caused by non-tuberculous mycobacteria. 
  NY - 1/1/2013
• The microbiology of non-tuberculous mycobacteria. 
  NY - 1/1/2013
• Update on Tuberculosis Clinical Trials. 
  Paris - 1/1/2013
• Ethical Issues in Tuberculosis Clinical Trials. 
  Paris - 1/1/2013
• Tuberculosis at home and abroad. 
  Stamford Hospital, Stamford, CT - 1/1/2013
• Effect of U.S. Federal budget cuts on TB research. 
  Philadelphia - 1/1/2013
• New drug regimens for tuberculosis. 
  New York City - 1/1/2013
• Clinical trials in tuberculosis. 
  Weill Cornell Medical College, New York City - 1/1/2013
• New drugs for tuberculosis. 
  Gainesville, FL - 1/1/2012
• The continuing global challenge of tuberculosis. 
  SUNY-Stony Brook, Stony Brook, NY - 1/1/2012
• Use of interferon gamma release assays in special populations. 
  SUNY-Stony Brook, Stony Brook, NY - 1/1/2012
• Tuberculosis in health care workers. 
  New Jersey Medical School (UMDNJ) Global Tuberculosis Institute, Newark, NJ - 1/1/2012
• Health system strengthening to fight TB. 
  Almaty, Kazakhstan - 1/1/2012
• Treatment of MDR and XDR TB. 
  Almaty, Kazakhstan - 1/1/2012
• Join now to see all

Other

• Fighting Tuberculosis. 
  Schluger N, The Economist
  http://www.economistinsights.com/healthcare/opinion/fighting-tuberculosis
  1/14/2014
• Institutional complacency raises threat. 
  Schluger NW, Financial Times
  http://www.ft.com/intl/cms/s/0/14735002-9142-11e2-b4c9-00144feabdc0.html#axzz2OGV1bUec
  1/22/2013
• Tuberculosis in HIV-infected patients: epidemiology, pathogenesis, treatment. 
  Schluger NW, Burzynski J, HIV Clinical Trials
  1/1/2001
• Multidrug-Resistant Tuberculosis. 
  Schluger NW, Pulmonary Perspectives
  1/1/1996
• Join now to see all